{"id":"https://openalex.org/W1864699017","doi":null,"title":"Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.","display_name":"Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.","publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W1864699017","mag":"1864699017","pmid":"https://pubmed.ncbi.nlm.nih.gov/8388318"},"language":"en","primary_location":{"id":"pmid:8388318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8388318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109423752","display_name":"Lloyd R. K\u00e8lland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L R Kelland","raw_affiliation_strings":["Drug Development Section, Institute of Cancer Research, Belmont, Sutton, Surrey, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Section, Institute of Cancer Research, Belmont, Sutton, Surrey, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005892782","display_name":"G Abel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Abel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038498358","display_name":"Mark James McKeage","orcid":"https://orcid.org/0000-0002-7329-5503","observed_orcids":["https://orcid.org/0000-0002-7329-5503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J McKeage","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109837812","display_name":"Mervyn Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Jones","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053571204","display_name":"Phyllis M. Goddard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P M Goddard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Valenti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Valenti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110468444","display_name":"Barry A. Murrer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B A Murrer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109973339","display_name":"Kenneth R. Harrap","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K R Harrap","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4715,"has_fulltext":false,"cited_by_count":224,"citation_normalized_percentile":{"value":0.95316649,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"53","issue":"11","first_page":"2581","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platinum-iv-complexes","display_name":"platinum(IV) complexes","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.906000018119812},{"id":"https://openalex.org/keywords/acquired-resistance","display_name":"acquired resistance","score":0.6439999938011169},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.7879999876022339},{"id":"https://openalex.org/keywords/ovarian-carcinoma","display_name":"ovarian carcinoma","score":0.6690000295639038},{"id":"https://openalex.org/keywords/plasmacytoma","display_name":"plasmacytoma","score":0.7590000033378601},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7870000004768372},{"id":"https://openalex.org/keywords/split-dosing","display_name":"split dosing","score":0.5400000214576721},{"id":"https://openalex.org/keywords/tetraplatin","display_name":"tetraplatin","score":0.7789999842643738},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.921999990940094},{"id":"https://openalex.org/keywords/platinum-uptake","display_name":"platinum uptake","score":0.6389999985694885},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.9167484045028687},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8212120532989502},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.749948263168335},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6441306471824646},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5993527770042419},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5659079551696777},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5315738916397095},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41380977630615234},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3754459023475647},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28231364488601685},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27224820852279663},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26903069019317627},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25940385460853577},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22758537530899048},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22035327553749084},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009373","descriptor_name":"Neoplasms, Germ Cell and Embryonal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010954","descriptor_name":"Plasmacytoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013736","descriptor_name":"Testicular Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8388318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8388318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},{"id":"mag:1864699017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8388318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1991177374","https://openalex.org/W1491330323","https://openalex.org/W2220965173","https://openalex.org/W135889629","https://openalex.org/W2372942625","https://openalex.org/W2123813244","https://openalex.org/W2019583985","https://openalex.org/W1490717809","https://openalex.org/W1542349909","https://openalex.org/W2081284509"],"abstract_inverted_index":{"The":[0,95],"cytotoxicity":[1,74,78,96],"of":[2,18,26,28,38,77,85,97,105,110,133,154,173,229],"a":[3,16,118,124,266,282],"novel":[4],"platinum(IV)":[5,8],"complex,":[6],"bis-acetato-amminedichloro-cyclohexylamine":[7],"(JM216),":[9],"has":[10,45,186],"been":[11,46],"evaluated":[12],"in":[13,48,128,157,166,171],"vitro":[14],"against":[15,64],"panel":[17],"human":[19,57,66,138,225],"tumor":[20,139],"cell":[21,69,140],"lines":[22,141,177],"(predominantly":[23],"ovarian)":[24],"representative":[25],"models":[27],"intrinsic":[29],"and":[30,55,75,90,136,146,179,235,250,252,280],"acquired":[31,134,175,276],"to":[32,79,189,193,214,233,243,255,269,278],"cisplatin.":[33],"In":[34,62,197],"addition,":[35],"the":[36,42,51,103,174,203],"activity":[37],"JM216":[39,71,98,149,182,208,237,264],"administered":[40,248,257],"by":[41],"p.o.":[43,200,239,287],"route":[44],"determined":[47],"vivo":[49],"using":[50,202],"murine":[52,205],"ADJ/PC6":[53,206],"plasmacytoma":[54],"four":[56,224],"ovarian":[58,67,226],"carcinoma":[59,68,227],"xenograft":[60],"lines.":[61],"vitro,":[63],"seven":[65],"lines,":[70],"showed":[72,209],"similar":[73],"pattern":[76],"cisplatin":[80,89,234,249,279],"(mean":[81],"50%":[82],"inhibitory":[83],"concentrations":[84],"3.5":[86],"microM":[87,92],"for":[88,93,217,246,291],"1.7":[91],"JM216).":[94],"was":[99],"more":[100,125],"dependent":[101],"on":[102],"time":[104],"drug":[106],"exposure":[107],"than":[108,117],"that":[109,113,215,244,263],"cisplatin,":[111,219],"suggesting":[112],"extended":[114],"split-dosing":[115],"rather":[116],"single":[119],"bolus":[120],"administration":[121,201],"might":[122],"be":[123,190],"appropriate":[126],"schedule":[127],"patients.":[129],"Using":[130],"six":[131,168],"pairs":[132],"cisplatin-resistant":[135,176],"parent":[137],"(four":[142],"ovarian,":[143],"one":[144,147],"testicular,":[145],"cervical)":[148],"exhibited":[150,161,238],"non-cross-resistance":[151],"(resistance":[152],"factor":[153],"<":[155],"1.5)":[156],"three":[158],"whereas":[159],"tetraplatin":[160],"partial":[162],"or":[163,221],"full":[164],"cross-resistance":[165],"all":[167],"pairs.":[169],"Notably,":[170],"two":[172],"(41McisR":[178],"HX/155cisR)":[180],"where":[181],"retained":[183],"activity,":[184,240],"resistance":[185,277],"previously":[187],"shown":[188],"due":[191],"primarily":[192],"reduced":[194],"platinum":[195,270,289],"uptake.":[196],"vivo,":[198],"following":[199],"cisplatin-sensitive":[204],"plasmacytoma,":[207],"antitumor":[210,260],"selectivity":[211],"far":[212],"superior":[213,254],"observed":[216,245],"either":[218],"carboplatin,":[220,236],"tetraplatin.":[222,258],"Across":[223],"xenografts":[228],"widely":[230],"differing":[231],"sensitivity":[232],"broadly":[241],"comparable":[242],"i.v.":[247],"carboplatin":[251],"markedly":[253],"i.p.":[256],"These":[259],"properties":[261],"suggest":[262],"provides":[265],"structural":[267],"lead":[268],"complexes":[271],"which":[272],"may":[273],"circumvent":[274],"transport-determined":[275],"is":[281],"suitable":[283],"candidate":[284],"as":[285],"an":[286],"administrable":[288],"complex":[290],"phase":[292],"I":[293],"clinical":[294],"trial.":[295]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":11}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}